Weihao Xu
Finanzdirektor/CFO bei HBM HOLDINGS LIMITED
Aktive Positionen von Weihao Xu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HBM HOLDINGS LIMITED | Finanzdirektor/CFO | 11.11.2022 | - |
Corporate Officer/Principal | 01.12.2021 | 11.11.2022 |
Karriereverlauf von Weihao Xu
Ehemalige bekannte Positionen von Weihao Xu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Matthews International Capital Management LLC
Matthews International Capital Management LLC Investment ManagersFinance Matthews International Capital Management LLC (dba Matthews Asia) is an independent SEC-registered investment advisor and mutual fund manager headquartered in San Francisco, California. The firm was founded by Paul Matthews in 1991. Matthews Asia manages portfolios for institutional clients, pension and profit-sharing plans, insurance companies, endowments and foundations and other business entities around the world. Institutional clients include funds registered under the laws of Luxembourg, United Kingdom, Ireland and Canada. | Portfolio Manager-Aktien | 01.01.2019 | 01.01.2020 |
Matthews International Capital Management LLC
Matthews International Capital Management LLC Investment ManagersFinance Matthews International Capital Management LLC (dba Matthews Asia) is an independent SEC-registered investment advisor and mutual fund manager headquartered in San Francisco, California. The firm was founded by Paul Matthews in 1991. Matthews Asia manages portfolios for institutional clients, pension and profit-sharing plans, insurance companies, endowments and foundations and other business entities around the world. Institutional clients include funds registered under the laws of Luxembourg, United Kingdom, Ireland and Canada. | Corporate Officer/Principal | 01.01.2016 | 01.01.2018 |
The Permal Group Ltd.
The Permal Group Ltd. Investment Trusts/Mutual FundsMiscellaneous The Permal Group Ltd. provides asset management services. It offers multi-manager and single manager funds, separate accounts and structured products. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.2014 | 01.01.2016 |
Lansdowne Partners (UK) LLP
Lansdowne Partners (UK) LLP Investment ManagersFinance Lansdowne Partners (UK) LLP (Lansdowne) is the alternative investment management subsidiary of Lansdowne Partners Ltd., itself a subsidiary of Lansdowne Partners International Ltd. in the Cayman Islands. The firm is headquartered in London and was founded in 1998. Lansdowne provides investment advisory services on a discretionary basis to their clients, which includes commingled investment vehicles intended for institutional investors and other sophisticated investors and investment vehicles formed for particular investors and separately managed accounts for sophisticated financial institutions, including registered investment companies. Lansdowne is a signatory to the United Nations Principles of Responsible Investing (UNPRI). | Corporate Officer/Principal | 01.01.2012 | 01.01.2014 |
ALPHAMAB ONCOLOGY | Finanzdirektor/CFO | 30.03.2021 | - |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Comptroller/Controller/Auditor | 16.12.2020 | - |
Finanzdirektor/CFO | 16.12.2020 | - |
Ausbildung von Weihao Xu
Stony Brook University | Undergraduate Degree |
Columbia Business School | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
China | 3 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 4 |
Director of Finance/CFO | 3 |
Portfolio Manager-Equities | 1 |
Sektoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ALPHAMAB ONCOLOGY | Health Technology |
HBM HOLDINGS LIMITED | Health Technology |
Private Unternehmen | 4 |
---|---|
Matthews International Capital Management LLC
Matthews International Capital Management LLC Investment ManagersFinance Matthews International Capital Management LLC (dba Matthews Asia) is an independent SEC-registered investment advisor and mutual fund manager headquartered in San Francisco, California. The firm was founded by Paul Matthews in 1991. Matthews Asia manages portfolios for institutional clients, pension and profit-sharing plans, insurance companies, endowments and foundations and other business entities around the world. Institutional clients include funds registered under the laws of Luxembourg, United Kingdom, Ireland and Canada. | Finance |
The Permal Group Ltd.
The Permal Group Ltd. Investment Trusts/Mutual FundsMiscellaneous The Permal Group Ltd. provides asset management services. It offers multi-manager and single manager funds, separate accounts and structured products. The company is headquartered in New York, NY. | Miscellaneous |
Lansdowne Partners (UK) LLP
Lansdowne Partners (UK) LLP Investment ManagersFinance Lansdowne Partners (UK) LLP (Lansdowne) is the alternative investment management subsidiary of Lansdowne Partners Ltd., itself a subsidiary of Lansdowne Partners International Ltd. in the Cayman Islands. The firm is headquartered in London and was founded in 1998. Lansdowne provides investment advisory services on a discretionary basis to their clients, which includes commingled investment vehicles intended for institutional investors and other sophisticated investors and investment vehicles formed for particular investors and separately managed accounts for sophisticated financial institutions, including registered investment companies. Lansdowne is a signatory to the United Nations Principles of Responsible Investing (UNPRI). | Finance |
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |